Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Embark

Embark
2015 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Series A LATEST DEAL TYPE
$13M LATEST DEAL AMOUNT
13 INVESTORS
Description

Provider of an animal DNA testing kit designed to improve dog health and wellness. The company's DNA testing kit looks at over 200,000 genetic markers to empower dog owners with vital health information, offering ancestry analysis as well as key insights into genetic disease risk and heritable traits, enabling pet owners to learn about their dog's breed, ancestry, relatives, health and what diseases may be in the future - all with a simple cheek swab.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Clinics/Outpatient Services
Primary Office
  • 186 Lincoln Street
  • 6th floor
  • Boston, MA 02111
  • United States

+1 (224) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Embark’s full profile, request a free trial.

Embark Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 29-Mar-2019 $13M 000.00 000.00 Completed Generating Revenue
3. Seed Round 26-Jun-2017 00.000 00.000 000.00 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Embark Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A-2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A-1 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Seed 4 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 3 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 2 486,969 $0.000100 5% $0.53 $0.53 1x $0.53 1.23%
Seed 1 6,801,684 $0.000100 5% $0.66 $0.66 1x $0.66 17.12%
To view this company’s complete Cap Table, request access »

Embark Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000 Private Debt Financed McLean, VA 000000 000 000000000 000
To view this company’s complete list of competitors, request access »

Embark Subsidiaries (1)

Company Name Industry Location Founded
000000000 00000000 Public Pension Fund Salisbury, United Kingdom 0000
To view this company’s complete subsidiary history, request access »

Embark Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
AGO Partners Venture Capital Minority 000 0000 000000 0
Anne Wojcicki Angel (individual) Minority 000 0000 000000 0
FJ Labs Venture Capital Minority 000 0000 000000 0
Founder Collective Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Embark Executive Team (10)

Name Title Board
Seat
Contact
Info
Ryan Boyko Ph.D Co-Founder, Chief Executive Officer & Board Member
Matt Barton Chief Technology Officer
Hannah Russin Chief Marketing Officer
Adam Boyko Co-Founder, Chief Science Officer & Board Member
Matthew Salzberg Co-Founder & Board Member

4 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Embark Board Members (5)

Name Representing Role Since Contact
Info
Adam Boyko Embark Co-Founder, Chief Science Officer & Board Member 000 0000
Carl Byers F-Prime Capital Partners Board Member 000 0000
Eric Paley Founder Collective Board Member 000 0000
Matthew Salzberg Embark Co-Founder & Board Member 000 0000
Ryan Boyko Ph.D Embark Co-Founder, Chief Executive Officer & Board Member 000 0000